Create Account

One Health helps you track and understand your health simply.

Create Account

One Health helps you track and understand your health simply.

Factor VII

Coagulation

Factor VII activityFVIIProconvertin

Review status

Currently under review

Pending specialist review and validation.

What it shows

Factor VII is a clotting protein made in the liver that needs vitamin K to function. The test measures the functional activity of factor VII in your plasma, showing how effectively it helps start the clotting process through the extrinsic pathway. A healthcare professional draws blood into a citrate tube, and the laboratory performs a specialized clotting assay to assess activity.

This test is often used alongside the prothrombin time and other factor assays to help find the cause of unusual bleeding or bruising, to assess liver synthetic function, and to evaluate the effects of vitamin K status or certain medicines.

Why it matters

If factor VII activity is too low, you may be more likely to bruise or bleed, especially after injury or procedures. Very low levels can be due to a rare inherited condition, liver disease, or vitamin K deficiency, and can also occur with medicines that block vitamin K. Higher activity can be seen with inflammation, estrogen exposure, or pregnancy, and in some situations may relate to a higher risk of unwanted clotting.

Your clinician may order this test if your prothrombin time is prolonged, if there is a history of bleeding, before surgery, when monitoring vitamin K therapy, or to help evaluate liver disorders. The result helps guide next steps, which can include treating an underlying condition or adjusting medications.

Understanding your results

Your result is interpreted together with your history, examination, other coagulation tests, and medicines. A low result can reflect vitamin K deficiency, reduced liver production, the effect of vitamin K antagonists, or a rare inherited deficiency. A high result can be seen with inflammation, hormonal changes, or during pregnancy. Isolated changes may also be reagent related, so repeat testing can be helpful.

If your result is not expected, your clinician may consider repeating the test, checking vitamin K status, reviewing medications, or ordering additional studies such as mixing studies, other factor assays, or liver evaluation. Management focuses on the cause, which may include nutrition support, medication adjustment, or specialist referral when needed.

Reference ranges

0.51.5 U/mL
All sexes
0 days – 150 years

Reference intervals vary by laboratory, analyzer, methodology, population, and units. The ranges shown here are for education only. Always interpret your results against the reference interval printed on your own lab report.

Factors that could impact Factor VII

  • Vitamin K status and nutrition

    Low intake, poor absorption, or recent antibiotic use can reduce vitamin K and lower factor VII activity. Your clinician may ask about diet, supplements, and gastrointestinal issues.

  • Medications that affect clotting

    Vitamin K antagonists such as warfarin lower factor VII activity. Some antibiotics and herbal products can interact with these medicines and change results.

  • Liver health

    Factor VII is made in the liver. Liver inflammation or scarring can reduce production, leading to lower activity on testing.

  • Pregnancy and estrogen exposure

    Pregnancy, oral contraceptives, or estrogen therapy can increase factor VII activity. Your healthcare team interprets results in this context.

  • Acute illness and inflammation

    Illness, stress, or inflammation can shift clotting protein levels. Temporary changes may normalize when you recover.

  • Sample collection and handling

    Underfilled citrate tubes, prolonged tourniquet time, delayed processing, or significant hemolysis can distort activity results. Proper collection helps ensure accuracy.

2026

References

  1. McGill University Health Centre. (2015, March 01). Factor VII. Laboratory reference ranges.
  2. Clinical and Laboratory Standards Institute. (2014). Collection, transport, and processing of blood specimens for testing plasma-based coagulation assays and molecular hemostasis assays (5th ed.). CLSI H21-A5.
  3. British Society for Haematology. (2020). Guidelines on the laboratory investigation of bleeding disorders.
  4. Srivastava, A., Santagostino, E., Dougall, A., Kitchen, S., Sutherland, M., Pipe, S. W., & World Federation of Hemophilia. (2020). WFH guidelines for the management of hemophilia (3rd ed.).